JP6849635B2 - 軟組織をマーキングするための外科インプラント - Google Patents
軟組織をマーキングするための外科インプラント Download PDFInfo
- Publication number
- JP6849635B2 JP6849635B2 JP2018126533A JP2018126533A JP6849635B2 JP 6849635 B2 JP6849635 B2 JP 6849635B2 JP 2018126533 A JP2018126533 A JP 2018126533A JP 2018126533 A JP2018126533 A JP 2018126533A JP 6849635 B2 JP6849635 B2 JP 6849635B2
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- marker
- radiation
- cavity
- implant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007943 implant Substances 0.000 title description 75
- 210000004872 soft tissue Anatomy 0.000 title description 13
- 239000003550 marker Substances 0.000 claims description 75
- 230000005855 radiation Effects 0.000 claims description 70
- 238000003384 imaging method Methods 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 24
- 230000002093 peripheral effect Effects 0.000 claims description 24
- 238000012800 visualization Methods 0.000 claims description 19
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 5
- 238000000465 moulding Methods 0.000 claims description 4
- 230000002745 absorbent Effects 0.000 claims description 2
- 239000002250 absorbent Substances 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 239000002861 polymer material Substances 0.000 claims description 2
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 239000010935 stainless steel Substances 0.000 claims description 2
- 239000010936 titanium Substances 0.000 claims description 2
- 229910052719 titanium Inorganic materials 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 description 141
- 206010028980 Neoplasm Diseases 0.000 description 51
- 238000011282 treatment Methods 0.000 description 43
- 238000000034 method Methods 0.000 description 30
- 238000002271 resection Methods 0.000 description 29
- 210000000481 breast Anatomy 0.000 description 24
- 238000001356 surgical procedure Methods 0.000 description 23
- 238000001959 radiotherapy Methods 0.000 description 19
- 238000012384 transportation and delivery Methods 0.000 description 13
- 206010006187 Breast cancer Diseases 0.000 description 12
- 208000026310 Breast neoplasm Diseases 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 11
- 230000001225 therapeutic effect Effects 0.000 description 9
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 238000002604 ultrasonography Methods 0.000 description 7
- 238000013461 design Methods 0.000 description 6
- 238000002513 implantation Methods 0.000 description 6
- 238000001746 injection moulding Methods 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 238000002595 magnetic resonance imaging Methods 0.000 description 6
- 206010040102 Seroma Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000001788 irregular Effects 0.000 description 5
- 238000013439 planning Methods 0.000 description 5
- 230000008685 targeting Effects 0.000 description 5
- 238000004804 winding Methods 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000009607 mammography Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000004626 polylactic acid Substances 0.000 description 4
- 238000003856 thermoforming Methods 0.000 description 4
- 229920000954 Polyglycolide Polymers 0.000 description 3
- 208000002847 Surgical Wound Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000002725 brachytherapy Methods 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229920000747 poly(lactic acid) Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000037390 scarring Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000002059 diagnostic imaging Methods 0.000 description 2
- 238000002710 external beam radiation therapy Methods 0.000 description 2
- 238000011347 external beam therapy Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 0 CC1(*C1)*1CCCC1 Chemical compound CC1(*C1)*1CCCC1 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- -1 Davis & Geck) Polymers 0.000 description 1
- 229920004937 Dexon® Polymers 0.000 description 1
- 206010019695 Hepatic neoplasm Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241001201483 Selenia <moth> Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000009093 first-line therapy Methods 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 229940084910 gliadel Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000002786 image-guided radiation therapy Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000002355 open surgical procedure Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000012831 peritoneal equilibrium test Methods 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920000232 polyglycine polymer Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 238000012636 positron electron tomography Methods 0.000 description 1
- 238000012877 positron emission topography Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000002603 single-photon emission computed tomography Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1014—Intracavitary radiation therapy
- A61N5/1015—Treatment of resected cavities created by surgery, e.g. lumpectomy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3904—Markers, e.g. radio-opaque or breast lesions markers specially adapted for marking specified tissue
- A61B2090/3908—Soft tissue, e.g. breast tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3954—Markers, e.g. radio-opaque or breast lesions markers magnetic, e.g. NMR or MRI
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3966—Radiopaque markers visible in an X-ray image
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/12—Mammary prostheses and implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/005—Templates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/041—Controlled or regulated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/58—Calibration of imaging systems, e.g. using test probes, Phantoms; Calibration objects or fiducial markers such as active or passive RF coils surrounding an MR active material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Prostheses (AREA)
- Radiation-Therapy Devices (AREA)
Description
Claims (9)
- 装置であって、
空洞部境界を有する外科的に形成された空洞部内に配置するための形状及びサイズを有する生体吸収性開骨格本体であって、前記本体は、前記外科的に形成された空洞部内に配置された時に球形状を有する前記装置の周辺境界が前記空洞部境界を規定するように前記装置の前記周辺境界を形成する第1対の分岐部及び第2対の分岐部を有し、前記第1対の分岐部及び前記第2対の分岐部は前記周辺境界に沿って延在し、前記第2対の分岐部は、前記装置の前記周辺境界に沿って前記第1対の分岐部に交差し、かつ、組織又は縫合糸が前記分岐部の間を通過して前記装置内に入ることを可能にするために十分に離間しており、前記本体は、前記外科的に形成された空洞部内への配置前、配置中及び配置後に前記空洞部境界の輪郭を規定し、かつ、前記球形状を維持するために十分な剛性をさらに有する、生体吸収性開骨格本体と、
空間を空けた構成で前記分岐部に固定された複数の放射線不透過性マーカーであって、前記空間を空けた構成は、前記装置の前記周辺境界に前記複数の放射線不透過性マーカーのうちの少なくとも1つの放射線不透過性マーカーを備え、前記第2対の分岐部のうちの一方に前記複数の放射線不透過性マーカーの少なくとも別の1つの放射線不透過性マーカーを備える、複数の放射線不透過性マーカーと、を備える装置。 - 前記放射線不透過性マーカーは、クリップを圧入して取り付けることができる前記本体の成形孔を用いて前記本体に取り付けられる、請求項1に記載の装置。
- 少なくとも4つの前記放射線不透過性マーカーが前記分岐部に沿って配置される、請求項1に記載の装置。
- 少なくとも2つの前記放射線不透過性マーカーが前記分岐部に沿って配置される、請求項1に記載の装置。
- 前記装置は2cm〜8cmの範囲のサイズを有する、請求項1に記載の装置。
- 前記装置は、ばねのように圧縮時に曲がるように構成される、請求項1に記載の装置。
- 前記放射線不透過性マーカーは、放射線イメージング装置によって可視化される、請求項1に記載の装置。
- 前記放射線不透過性マーカーの配置は、前記放射線イメージング装置の下で前記空洞部境界の可視化を最適化する、請求項7に記載の装置。
- 前記放射線不透過性マーカーは、チタン、ステンレス鋼、金及び複合ポリマー材料のうちの少なくとも1つを含む放射線不透過性材料から形成される、請求項1に記載の装置。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/456,435 US20130289389A1 (en) | 2012-04-26 | 2012-04-26 | Surgical implant for marking soft tissue |
US13/456,435 | 2012-04-26 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015509125A Division JP6366572B2 (ja) | 2012-04-26 | 2013-04-25 | 軟組織をマーキングするための外科インプラント |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018171483A JP2018171483A (ja) | 2018-11-08 |
JP2018171483A5 JP2018171483A5 (ja) | 2019-07-04 |
JP6849635B2 true JP6849635B2 (ja) | 2021-03-24 |
Family
ID=49477870
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015509125A Active JP6366572B2 (ja) | 2012-04-26 | 2013-04-25 | 軟組織をマーキングするための外科インプラント |
JP2018126533A Active JP6849635B2 (ja) | 2012-04-26 | 2018-07-03 | 軟組織をマーキングするための外科インプラント |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015509125A Active JP6366572B2 (ja) | 2012-04-26 | 2013-04-25 | 軟組織をマーキングするための外科インプラント |
Country Status (7)
Country | Link |
---|---|
US (5) | US20130289389A1 (ja) |
EP (3) | EP3695802B1 (ja) |
JP (2) | JP6366572B2 (ja) |
AU (1) | AU2013251545B2 (ja) |
CA (1) | CA2871606A1 (ja) |
ES (2) | ES2924369T3 (ja) |
WO (1) | WO2013163381A1 (ja) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9014787B2 (en) * | 2009-06-01 | 2015-04-21 | Focal Therapeutics, Inc. | Bioabsorbable target for diagnostic or therapeutic procedure |
US20130289389A1 (en) | 2012-04-26 | 2013-10-31 | Focal Therapeutics | Surgical implant for marking soft tissue |
US8989843B2 (en) * | 2012-06-05 | 2015-03-24 | DePuy Synthes Products, LLC | Methods and apparatus for estimating the position and orientation of an implant using a mobile device |
USD716450S1 (en) | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD716451S1 (en) * | 2013-09-24 | 2014-10-28 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715942S1 (en) | 2013-09-24 | 2014-10-21 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
USD715442S1 (en) * | 2013-09-24 | 2014-10-14 | C. R. Bard, Inc. | Tissue marker for intracorporeal site identification |
US20160287901A1 (en) * | 2013-11-08 | 2016-10-06 | Dumaine Precision Inc. | Surgical cavity sizers for brachytherapy and intraoperative radiation therapy |
US11883275B2 (en) | 2014-06-11 | 2024-01-30 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11638640B2 (en) | 2014-06-11 | 2023-05-02 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
AU2015292332A1 (en) * | 2014-07-25 | 2017-02-16 | Focal Therapeutics, Inc. | Implantable devices and techniques for oncoplastic surgery |
ES2886675T3 (es) * | 2015-06-30 | 2021-12-20 | Canon Usa Inc | Marcadores fiduciarios, sistemas, y procedimientos de registro |
US9949821B2 (en) * | 2015-12-22 | 2018-04-24 | Biosense Webster (Israel) Ltd. | Colored silicone for implant safety |
EP3463166A1 (en) | 2016-06-03 | 2019-04-10 | SOMATEX Medical Technologies GmbH | Marking device and implantation system |
KR101876457B1 (ko) * | 2016-10-13 | 2018-07-10 | 연세대학교 산학협력단 | 흉벽의 두께를 보정하기 위한 맞춤형 볼러스 및 이의 제조 방법 |
CN110022789B (zh) | 2016-11-23 | 2022-07-12 | 霍罗吉克公司 | 活检部位标记物 |
US11219502B2 (en) | 2017-09-11 | 2022-01-11 | Medtronic Advanced Energy, Llc | Transformative shape-memory polymer tissue cavity marker devices, systems and deployment methods |
US10646727B2 (en) | 2017-11-13 | 2020-05-12 | Positive Energy, Llc | Anchored brachytherapy device |
EP3723618B1 (en) | 2017-12-11 | 2023-11-29 | Hologic, Inc. | Ultrasound localization system with advanced biopsy site markers |
US11324567B2 (en) | 2018-02-01 | 2022-05-10 | Medtronic Advanced Energy, Llc | Expandable tissue cavity marker devices, systems and deployment methods |
US11759306B2 (en) | 2018-03-12 | 2023-09-19 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
US11259913B2 (en) | 2019-02-06 | 2022-03-01 | Susan Scott | Breast implant with position marker |
US11504546B2 (en) | 2019-02-28 | 2022-11-22 | Cowles Ventures, Llc | Needle guidance device for brachytherapy and method of use |
US11524176B2 (en) | 2019-03-14 | 2022-12-13 | Cowles Ventures, Llc | Locator for placement of fiducial support device method |
WO2020227540A1 (en) | 2019-05-08 | 2020-11-12 | Atricure, Inc. | Biological tissue position location and marking |
CN112336332A (zh) * | 2019-08-09 | 2021-02-09 | 通用电气精准医疗有限责任公司 | 磁共振成像扫描方法及磁共振成像系统 |
CN110507451A (zh) * | 2019-08-29 | 2019-11-29 | 上海翰凌医疗器械有限公司 | 瓣膜支架及具有其的人工瓣膜 |
US11406489B2 (en) | 2019-10-07 | 2022-08-09 | Cornell University | Implant with fiducial markers |
US20210220522A1 (en) * | 2020-01-16 | 2021-07-22 | Hologic, Inc. | Hydrogel-based implantable device and related methods |
US20230038320A1 (en) * | 2020-02-06 | 2023-02-09 | Somatex Medical Technologies Gmbh | Implantable marker body for breast treatment |
AU2020437689A1 (en) | 2020-03-23 | 2022-10-06 | Bard Shannon Limited | In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material |
JP2023522167A (ja) | 2020-04-06 | 2023-05-29 | テファ, インコーポレイテッド | 手術部位をマーキングする医療用インプラント |
US11602426B2 (en) * | 2020-10-23 | 2023-03-14 | Andrew Weems | Void occlusion device |
US11701451B1 (en) | 2022-03-11 | 2023-07-18 | Carbon Medical Technologies, Inc. | Soft tissue filler and methods |
WO2024077231A1 (en) | 2022-10-07 | 2024-04-11 | Hologic, Inc. | Implantable, bioabsorbable surgical implants and methods for fabricating the same |
Family Cites Families (113)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3157524A (en) | 1960-10-25 | 1964-11-17 | Ethicon Inc | Preparation of collagen sponge |
US3520402A (en) | 1967-08-30 | 1970-07-14 | Ethicon Inc | Purified collagen fibrils |
US4298998A (en) | 1980-12-08 | 1981-11-10 | Naficy Sadeque S | Breast prosthesis with biologically absorbable outer container |
US4832686A (en) | 1986-06-24 | 1989-05-23 | Anderson Mark E | Method for administering interleukin-2 |
US5019087A (en) | 1986-10-06 | 1991-05-28 | American Biomaterials Corporation | Nerve regeneration conduit |
US5545229A (en) | 1988-08-18 | 1996-08-13 | University Of Medicine And Dentistry Of Nj | Functional and biocompatible intervertebral disc spacer containing elastomeric material of varying hardness |
US4957479A (en) | 1988-10-17 | 1990-09-18 | Vance Products Incorporated | Indwelling ureteral stent placement apparatus |
US5429582A (en) | 1991-06-14 | 1995-07-04 | Williams; Jeffery A. | Tumor treatment |
WO1995002376A1 (en) | 1993-07-12 | 1995-01-26 | The Regents Of The University Of California | Soft tissue augmentation apparatus |
US5626611A (en) | 1994-02-10 | 1997-05-06 | United States Surgical Corporation | Composite bioabsorbable materials and surgical articles made therefrom |
DE69534233T2 (de) * | 1994-09-16 | 2005-10-27 | Ethicon Endo-Surgery, Inc., Cincinnati | Vorrichtungen zum bestimmen und markieren von gewebe |
US5501706A (en) | 1994-11-29 | 1996-03-26 | Wildflower Communications, Inc. | Medical implant structure and method for using the same |
US5716404A (en) | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
US6071301A (en) | 1998-05-01 | 2000-06-06 | Sub Q., Inc. | Device and method for facilitating hemostasis of a biopsy tract |
US5853366A (en) | 1996-07-08 | 1998-12-29 | Kelsey, Inc. | Marker element for interstitial treatment and localizing device and method using same |
US5676146B1 (en) | 1996-09-13 | 2000-04-18 | Osteotech Inc | Surgical implant containing a resorbable radiopaque marker and method of locating such within a body |
FI105159B (fi) | 1996-10-25 | 2000-06-30 | Biocon Ltd | Kirurginen implantaatti, väline tai sen osa |
US5873865A (en) | 1997-02-07 | 1999-02-23 | Eclipse Surgical Technologies, Inc. | Spiral catheter with multiple guide holes |
US6477423B1 (en) | 1997-05-28 | 2002-11-05 | Transneuronix, Inc. | Medical device for use in laparoscopic surgery |
US6245103B1 (en) | 1997-08-01 | 2001-06-12 | Schneider (Usa) Inc | Bioabsorbable self-expanding stent |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6340367B1 (en) | 1997-08-01 | 2002-01-22 | Boston Scientific Scimed, Inc. | Radiopaque markers and methods of using the same |
US6638308B2 (en) | 1997-10-10 | 2003-10-28 | John D. Corbitt, Jr. | Bioabsorbable breast implant |
US7637948B2 (en) | 1997-10-10 | 2009-12-29 | Senorx, Inc. | Tissue marking implant |
JP2001519203A (ja) | 1997-10-10 | 2001-10-23 | ジョン・ディ・コービット・ジュニア | 胸部インプラント |
US8288745B2 (en) | 1997-10-10 | 2012-10-16 | Senorx, Inc. | Method of utilizing an implant for targeting external beam radiation |
US6030333A (en) * | 1997-10-24 | 2000-02-29 | Radiomed Corporation | Implantable radiotherapy device |
US6270464B1 (en) | 1998-06-22 | 2001-08-07 | Artemis Medical, Inc. | Biopsy localization method and device |
US6159165A (en) * | 1997-12-05 | 2000-12-12 | Micrus Corporation | Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand |
US6626939B1 (en) | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
US6161034A (en) | 1999-02-02 | 2000-12-12 | Senorx, Inc. | Methods and chemical preparations for time-limited marking of biopsy sites |
US6363940B1 (en) | 1998-05-14 | 2002-04-02 | Calypso Medical Technologies, Inc. | System and method for bracketing and removing tissue |
US6080099A (en) | 1998-08-12 | 2000-06-27 | Syntheon, Llc | Radioactive therapeutic seeds |
US8114006B2 (en) | 1998-10-06 | 2012-02-14 | University Of South Florida | Radio guided seed localization of imaged lesions |
AU2347300A (en) | 1998-11-25 | 2000-06-13 | Ball Semiconductor Inc. | Spherically-shaped biomedical ic |
US6356782B1 (en) | 1998-12-24 | 2002-03-12 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6371904B1 (en) * | 1998-12-24 | 2002-04-16 | Vivant Medical, Inc. | Subcutaneous cavity marking device and method |
US6725083B1 (en) | 1999-02-02 | 2004-04-20 | Senorx, Inc. | Tissue site markers for in VIVO imaging |
US20090216118A1 (en) | 2007-07-26 | 2009-08-27 | Senorx, Inc. | Polysaccharide markers |
US6766186B1 (en) | 1999-06-16 | 2004-07-20 | C. R. Bard, Inc. | Post biospy tissue marker and method of use |
US6575991B1 (en) * | 1999-06-17 | 2003-06-10 | Inrad, Inc. | Apparatus for the percutaneous marking of a lesion |
US6234177B1 (en) | 1999-08-12 | 2001-05-22 | Thomas Barsch | Apparatus and method for deploying an expandable biopsy marker |
US7935147B2 (en) * | 1999-10-20 | 2011-05-03 | Anulex Technologies, Inc. | Method and apparatus for enhanced delivery of treatment device to the intervertebral disc annulus |
US6203570B1 (en) | 1999-11-24 | 2001-03-20 | John L. Baeke | Breast implant with position lock |
US6893462B2 (en) | 2000-01-11 | 2005-05-17 | Regeneration Technologies, Inc. | Soft and calcified tissue implants |
CA2404092A1 (en) | 2000-04-11 | 2001-10-18 | James Teague | Reinforced retention structures |
US6579310B1 (en) * | 2000-08-17 | 2003-06-17 | Advanced Cardiovascular Systems, Inc. | Stent having overlapping struts |
US6746458B1 (en) | 2000-09-07 | 2004-06-08 | William G. Cloud | Mesh material to repair hernias |
MXPA03003852A (es) | 2000-11-01 | 2004-10-15 | Medi Physics Inc | Elemento radioactivo y metodo de elaboracion. |
US7776310B2 (en) * | 2000-11-16 | 2010-08-17 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
US6623510B2 (en) * | 2000-12-07 | 2003-09-23 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US7572287B2 (en) | 2001-10-25 | 2009-08-11 | Boston Scientific Scimed, Inc. | Balloon expandable polymer stent with reduced elastic recoil |
US7329414B2 (en) | 2002-05-03 | 2008-02-12 | Biopsy Sciences, Llc | Biodegradable polymer for marking tissue and sealing tracts |
CA2494377C (en) | 2002-08-01 | 2012-09-25 | James E. Selis | Biopsy devices and methods |
EP2221019B1 (en) | 2002-11-18 | 2012-01-04 | Bard Peripheral Vascular, Inc. | Percutaneous imaging marker |
US7081135B2 (en) | 2003-06-09 | 2006-07-25 | Lane Fielding Smith | Mastopexy stabilization apparatus and method |
US8211087B2 (en) | 2003-07-31 | 2012-07-03 | Cook Medical Technologies Llc | Distal wire stop |
US7498018B2 (en) | 2003-10-03 | 2009-03-03 | Bracco Diagnostics Inc. | Contrast media for use in medical and diagnostic procedures and methods of using the same |
US7524274B2 (en) | 2003-11-07 | 2009-04-28 | Cytyc Corporation | Tissue positioning systems and methods for use with radiation therapy |
US20050165480A1 (en) * | 2004-01-23 | 2005-07-28 | Maybelle Jordan | Endovascular treatment devices and methods |
US20050234336A1 (en) | 2004-03-26 | 2005-10-20 | Beckman Andrew T | Apparatus and method for marking tissue |
WO2006022786A1 (en) | 2004-08-20 | 2006-03-02 | David Mullen | Tissue marking devices and systems |
US8280486B2 (en) | 2004-10-13 | 2012-10-02 | Suros Surgical Systems, Inc. | Site marker visable under multiple modalities |
US8060183B2 (en) | 2004-10-13 | 2011-11-15 | Suros Surgical Systems, Inc. | Site marker visible under multiple modalities |
US20060079805A1 (en) | 2004-10-13 | 2006-04-13 | Miller Michael E | Site marker visable under multiple modalities |
US7662082B2 (en) | 2004-11-05 | 2010-02-16 | Theragenics Corporation | Expandable brachytherapy device |
US20060116713A1 (en) * | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
EP1681077A1 (en) * | 2005-01-12 | 2006-07-19 | Acrostak Corp. | A positioning device and a procedure for treating the walls of a resection cavity |
US20060247678A1 (en) | 2005-04-08 | 2006-11-02 | Weisenburgh William B Ii | Surgical instrument system |
US9788821B2 (en) * | 2005-04-29 | 2017-10-17 | Cook Biotech Incorporated | Physically modified extracellular matrix materials and uses thereof |
EP1741469A1 (en) | 2005-07-08 | 2007-01-10 | Engineers & Doctors Wallstén Medical A/S | Method of guiding an irradiation equipment |
DE602006008632D1 (de) * | 2005-07-11 | 2009-10-01 | Dsm Ip Assets Bv | Gerollter draht zur kontrollierten freisetzung von arzneimitteln an das auge |
US7736293B2 (en) | 2005-07-22 | 2010-06-15 | Biocompatibles Uk Limited | Implants for use in brachytherapy and other radiation therapy that resist migration and rotation |
US7815562B2 (en) | 2005-08-11 | 2010-10-19 | Boston Scientific Scimed, Inc. | Tubular implantable sling and related delivery systems, methods and devices |
CA2562580C (en) | 2005-10-07 | 2014-04-29 | Inrad, Inc. | Drug-eluting tissue marker |
US20070104695A1 (en) | 2005-11-07 | 2007-05-10 | Quijano Rodolfo C | Breast augmentation and reconstruction system |
US7887476B2 (en) * | 2005-11-10 | 2011-02-15 | Cianna Medical, Inc. | Helical brachytherapy apparatus and methods of using same |
WO2007106817A2 (en) * | 2006-03-14 | 2007-09-20 | Niyazi Beyhan | Methods and apparatus for imaging and treating hollow body cavities |
US7520876B2 (en) | 2006-04-21 | 2009-04-21 | Entellus Medical, Inc. | Device and method for treatment of sinusitis |
US20080082113A1 (en) | 2006-10-03 | 2008-04-03 | Alure Medical, Inc. | Minimally invasive tissue support |
EP2109409B1 (en) | 2006-12-12 | 2018-09-05 | C.R.Bard, Inc. | Multiple imaging mode tissue marker |
WO2008076973A2 (en) | 2006-12-18 | 2008-06-26 | C.R.Bard Inc. | Biopsy marker with in situ-generated imaging properties |
US7875059B2 (en) | 2007-01-18 | 2011-01-25 | Warsaw Orthopedic, Inc. | Variable stiffness support members |
US20080228164A1 (en) * | 2007-03-14 | 2008-09-18 | Nicoson Zachary R | Implant delivery system |
US20080243226A1 (en) * | 2007-03-30 | 2008-10-02 | Fernandez Jose E | Implantable stents with radiopaque markers and methods for manufacturing the same |
WO2008153713A1 (en) | 2007-05-23 | 2008-12-18 | Quantum Applied Science And Research, Inc. | Sensor mounting system |
ATE487441T1 (de) | 2007-06-01 | 2010-11-15 | Allergan Inc | Gerät zur erzeugung des zugspannungsinduzierten wachstums von biologischem gewebe |
US20090024225A1 (en) | 2007-07-16 | 2009-01-22 | Stubbs James B | Implant for Targeting Therapeutic Procedure |
CN101778607A (zh) | 2007-07-20 | 2010-07-14 | 卡吕普索医疗技术公司 | 用于外部束辐射治疗的可植入装置和方法 |
JP4281832B2 (ja) | 2007-10-25 | 2009-06-17 | トヨタ自動車株式会社 | 自動変速機の制御装置 |
WO2009076547A2 (en) | 2007-12-11 | 2009-06-18 | Massachusetts Institute Of Technology | Implantable drug delivery device ant) methods for treatment of the bladder and other body vestcles or lumens |
US8394116B2 (en) | 2008-04-15 | 2013-03-12 | The Regents Of The University Of Michigan | Surgical tools and components thereof |
US20090319046A1 (en) | 2008-06-23 | 2009-12-24 | Biomerix Corporation | Hyoid suspension for obstructive sleep apnea |
US9101395B2 (en) * | 2008-06-25 | 2015-08-11 | Koninklijke Philips N.V. | Method and system for brachytherapy |
WO2010051506A1 (en) | 2008-10-31 | 2010-05-06 | Alure Medical, Inc. | Minimally invasive tissue support system and method with a superior tissue support and an inferior anchor |
WO2010068467A1 (en) | 2008-11-25 | 2010-06-17 | Attenuex Technologies, Inc. | Implant with high vapor pressure medium |
US9014787B2 (en) | 2009-06-01 | 2015-04-21 | Focal Therapeutics, Inc. | Bioabsorbable target for diagnostic or therapeutic procedure |
US9386942B2 (en) * | 2009-06-26 | 2016-07-12 | Cianna Medical, Inc. | Apparatus, systems, and methods for localizing markers or tissue structures within a body |
EP3106089B1 (en) * | 2009-06-26 | 2020-12-02 | Cianna Medical, Inc. | System for localizing markers or tissue structures within a body |
US20110028831A1 (en) | 2009-07-30 | 2011-02-03 | Kent James P | Permanently visible implantable fiduciary tissue marker |
US9205577B2 (en) | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
WO2011146614A1 (en) | 2010-05-19 | 2011-11-24 | Transmed7, Llc | Methods and apparatus for in situ formation of surgical implants |
EP2608730B1 (en) | 2010-08-27 | 2019-07-24 | Ekos Corporation | Apparatus for treatment of intracranial hemorrhages |
ES2769324T3 (es) | 2011-03-09 | 2020-06-25 | Tepha Inc | Sistemas para mastopexia |
EP3216423A1 (en) | 2011-07-08 | 2017-09-13 | C.R. Bard Inc. | Implantable prothesis for reconstruction of an anatomical feature |
US20130289389A1 (en) | 2012-04-26 | 2013-10-31 | Focal Therapeutics | Surgical implant for marking soft tissue |
US20140100656A1 (en) | 2012-10-04 | 2014-04-10 | Innovative Biologics LLC | Restorative post-lumpectomy implant device |
US10286114B2 (en) | 2013-03-13 | 2019-05-14 | Focal Therapeutics, Inc. | Device and method for targeted radiation therapy |
ES2409691B1 (es) | 2012-11-16 | 2013-11-21 | Federico MAYO MARTIN | Implante mamario |
US9532867B2 (en) | 2013-07-11 | 2017-01-03 | Tepha, Inc. | Absorbable implants for plastic surgery |
US10130457B2 (en) | 2014-03-05 | 2018-11-20 | Tela Bio, Inc. | Surgical attachment device |
AU2015292332A1 (en) | 2014-07-25 | 2017-02-16 | Focal Therapeutics, Inc. | Implantable devices and techniques for oncoplastic surgery |
EP3954303A1 (en) | 2015-04-13 | 2022-02-16 | Levita Magnetics International Corp. | Grasper with magnetically-controlled positioning |
-
2012
- 2012-04-26 US US13/456,435 patent/US20130289389A1/en not_active Abandoned
- 2012-10-19 US US13/656,068 patent/US10413381B2/en active Active
-
2013
- 2013-04-25 WO PCT/US2013/038145 patent/WO2013163381A1/en active Application Filing
- 2013-04-25 ES ES20169119T patent/ES2924369T3/es active Active
- 2013-04-25 ES ES13782314T patent/ES2794936T3/es active Active
- 2013-04-25 EP EP20169119.3A patent/EP3695802B1/en active Active
- 2013-04-25 CA CA2871606A patent/CA2871606A1/en not_active Abandoned
- 2013-04-25 EP EP22173509.5A patent/EP4062860A1/en active Pending
- 2013-04-25 JP JP2015509125A patent/JP6366572B2/ja active Active
- 2013-04-25 EP EP13782314.2A patent/EP2840965B1/en active Active
- 2013-04-25 AU AU2013251545A patent/AU2013251545B2/en active Active
-
2018
- 2018-03-13 US US15/920,126 patent/US10500014B2/en active Active
- 2018-07-03 JP JP2018126533A patent/JP6849635B2/ja active Active
-
2019
- 2019-10-23 US US16/661,663 patent/US11529211B2/en active Active
-
2022
- 2022-09-27 US US17/953,996 patent/US11944509B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2840965A1 (en) | 2015-03-04 |
US11529211B2 (en) | 2022-12-20 |
EP3695802A1 (en) | 2020-08-19 |
US20200113647A1 (en) | 2020-04-16 |
US20130289389A1 (en) | 2013-10-31 |
AU2013251545A1 (en) | 2014-11-06 |
US10500014B2 (en) | 2019-12-10 |
WO2013163381A1 (en) | 2013-10-31 |
JP2018171483A (ja) | 2018-11-08 |
US20180200020A1 (en) | 2018-07-19 |
JP2015515355A (ja) | 2015-05-28 |
US11944509B2 (en) | 2024-04-02 |
US20230093141A1 (en) | 2023-03-23 |
US10413381B2 (en) | 2019-09-17 |
EP3695802B1 (en) | 2022-06-08 |
EP2840965A4 (en) | 2015-12-30 |
ES2794936T3 (es) | 2020-11-19 |
EP4062860A1 (en) | 2022-09-28 |
JP6366572B2 (ja) | 2018-08-01 |
US20130289390A1 (en) | 2013-10-31 |
CA2871606A1 (en) | 2013-10-31 |
ES2924369T3 (es) | 2022-10-06 |
EP2840965B1 (en) | 2020-04-15 |
AU2013251545B2 (en) | 2017-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6849635B2 (ja) | 軟組織をマーキングするための外科インプラント | |
US11752361B2 (en) | Diagnostic or therapeutic procedure using implantable targets | |
US11337772B2 (en) | Implant for targeting therapeutic procedure | |
JP4955212B2 (ja) | 軟組織ボリュームを識別するための細長いマーカー | |
US8454489B2 (en) | Implant comprising radioactive seeds | |
CN101102814A (zh) | 用于治疗切除空腔壁的定位装置和方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180731 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180731 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190531 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190813 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20191111 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200110 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200630 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200929 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210301 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210304 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6849635 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |